- C4 Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- C4 Therapeutics Inc To Discuss CFT7455 Phase 1 Update Call TranscriptDec 12, 2023
- C4 Therapeutics Inc at Stifel Targeted Oncology Days (Virtual) TranscriptApr 26, 2023
- C4 Therapeutics Inc at Wells Fargo Targeted Protein Degradation Summit (Virtual) - Panel Discussion TranscriptFeb 21, 2023
- C4 Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- C4 Therapeutics Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- C4 Therapeutics Inc at Bank of America Precision Oncology Conference TranscriptOct 03, 2022
- C4 Therapeutics Inc To Discuss CFT7455 Cohort Clinical Data Call TranscriptApr 08, 2022
- C4 Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- C4 Therapeutics Inc CFT8919 Pre-Clinical Data Call TranscriptJun 07, 2021
- C4 Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- C4 Therapeutics Inc at UBS Global Healthcare Virtual Conference TranscriptMay 26, 2021
- C4 Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
C4 Therapeutics Inc To Discuss CFT7455 Cohort Clinical Data Call Transcript
Good afternoon. Welcome to the C4 Therapeutics AACR Investor Call on CFT7455 Clinical Data. My name is Vanessa, and I will be your operator for today's call. (Operator Instructions)
I will now turn the call over to Kendra Adams, Senior Vice President, Communications and Investor Relations.
Good afternoon, everyone, and thank you for joining our call to discuss the clinical data for CFT7455 being presented at AACR. We will be making forward-looking statements today, and Slide 2 contains our legal disclaimer on this matter.
Joining me on the call this afternoon are Andrew Hirsch, our President and CEO; Adam Crystal, our CMO; and Dr. Lonial, an investigator for the CFT7455 Phase I/II trial. Dr. Lonial is a Professor and the Chair of Department of Hematology and Medical Oncology at the Winship Cancer Institute at Emory University. Stew Fisher, our CSO, will also join for the Q&A portion of the call.
I'll turn the call over to Andrew for some introductory remarks.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)